MET - Renal cell carcinoma, papillary type 1

This test is available for the following conditions:

  • Conditions > Renal / Nephrological > Renal cell carcinoma
  • Conditions > Oncogenetics > Renal cell carcinoma

This product is also part of the following panels:

  • Comprehensive preconception carrier test panel¹
  • Hearing impairment panel (including GJB2)
  • Hereditary cancer panel
  • Mendelian inherited disorders panel with genome wide CNV analysis
  • panel hereditary renalcancer (SDHA, SDHB, SDHC, SDHD, SDHAF2, VHL, PTEN, FLCN, MET, FH, BAP1)
  • Short stature/skeletal dysplasia panel with genome wide CNV analysis

Turnaround time
Complete analysis & Targeted analysis: 3 weeks

Method

  • Sequence analysis of all coding exons and flanking intron-exon boundaries

OMIM: 164860
Performing laboratory: Radboudumc
Authorized material(s): EDTA blood, FFPE, Isolated DNA




€ 509

Gene

MET - Renal cell carcinoma, papillary type 1

Turnaround time
Complete analysis & Targeted analysis: 3 weeks
Performing laboratory
Radboudumc
€ 509

MET - Renal cell carcinoma, papillary type 1



€ 509